PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 1.4500
- -0.0100-0.68%
Close Feb 14 16:00 ET
- 1.3614
- -0.0886-6.11%
Post 19:50 ET
1.84MMarket Cap-0.10P/E (TTM)
1.5380High1.4400Low170.21KVolume1.4800Open1.4600Pre Close251.05KTurnover18.73%Turnover RatioLossP/E (Static)1.27MShares9.250052wk High0.10P/B1.32MFloat Cap1.320052wk Low--Dividend TTM908.92KShs Float170.0000Historical High--Div YieldTTM6.71%Amplitude1.3200Historical Low1.4740Avg Price1Lot Size
About Pasithea Therapeutics Company
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Company Profile
SymbolKTTA
Company NamePasithea Therapeutics
Listing DateSep 15, 2021
Issue Price4.99
Founded2020
CEODr. Tiago Reis Marques
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address1111 Lincoln Road,Suite 500
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33139
Phone1-702-514-4174
Websitehttp://www.pasithea.com
Company Executives
- Name
- Position
- Salary
- Dr. Tiago Reis Marques
- Chief Executive Officer and Director
- --
- Dr. Graeme Martin Currie, PhD
- Chief Development Officer
- --
- Daniel Schneiderman
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Lawrence J. Steinman, M.D.
- Executive Chairman of the Board
- --
- Simon Dumesnil
- Independent Director
- --
- Alfred J Novak
- Independent Director
- --
- Dr. Emer Leahy
- Independent Director
- --
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025